Chimeric antigen receptors and regulatory T cells: the potential for HLA-specific immunosuppression in transplantation
Chimeric antigen receptors (CARs) are a breakthrough in genetic engineering that have revolutionized the field of adoptive cellular therapy (ACT). Cells expressing these receptors are rerouted to a predefined target by the inclusion of an antigen-specific binding region within the synthetic CAR cons...
Main Authors: | Wright, S, Hennessy, C, Hester, J, Issa, F |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2021
|
Similar Items
-
Engineering of a third-generation chimeric antigen receptor with specificity for HLA-A2 for use in regulatory T cell therapy
by: Wright, S
Published: (2022) -
Chimeric antigen receptor-modified human regulatory T cells that constitutively express IL-10 maintain their phenotype and are potently suppressive
by: Mohseni, YR, et al.
Published: (2021) -
Regulatory B cells in transplantation: roadmaps to clinic
by: Beckett, J, et al.
Published: (2020) -
Late treatment with autologous expanded regulatory T-cell therapy after alemtuzumab induction is safe and facilitates immunosuppression minimization in living donor renal transplantation
by: Brook, MO, et al.
Published: (2024) -
Overcoming the challenge of transduction of human T-cells with chimeric antigen receptor (CAR) specific for ERBB2 antigen
by: Munisvaradass, Rusheni, et al.
Published: (2017)